CVS Health (CVS) | Financial Analysis & Statements
CVS Health Corporation Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
105.7B
Gross Profit
13.6B
12.84%
Operating Income
2.1B
2.00%
Net Income
2.9B
2.77%
EPS (Diluted)
$2.30
Balance Sheet Metrics
Total Assets
253.5B
Total Liabilities
178.2B
Shareholders Equity
75.4B
Debt to Equity
2.36
Cash Flow Metrics
Operating Cash Flow
4.4B
Free Cash Flow
2.6B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
CVS Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 402.1B | 372.8B | 357.8B | 322.5B | 292.1B |
| Cost of Goods Sold | 346.7B | 321.4B | 303.3B | 268.0B | 240.0B |
| Gross Profit | 55.4B | 51.4B | 54.4B | 54.5B | 52.1B |
| Gross Margin % | 13.8% | 13.8% | 15.2% | 16.9% | 17.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 45.0B | 41.6B | 39.8B | 38.2B | 37.0B |
| Total Operating Expenses | 45.0B | 41.6B | 39.8B | 38.2B | 37.0B |
| Operating Income | 10.4B | 9.8B | 14.6B | 16.3B | 15.1B |
| Operating Margin % | 2.6% | 2.6% | 4.1% | 5.1% | 5.2% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 3.1B | 3.0B | 2.7B | 2.3B | 2.5B |
| Other Non-Operating Income | -5.1B | -689.0M | -768.0M | -8.2B | -2.1B |
| Pre-tax Income | 2.1B | 6.1B | 11.2B | 5.8B | 10.5B |
| Income Tax | 408.0M | 1.6B | 2.8B | 1.5B | 2.5B |
| Effective Tax Rate % | 19.1% | 25.4% | 25.1% | 25.9% | 24.2% |
| Net Income | 1.7B | 4.6B | 8.4B | 4.3B | 8.0B |
| Net Margin % | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% |
| Key Metrics | |||||
| EBITDA | 15.1B | 14.5B | 19.1B | 20.7B | 19.8B |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.00 |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $5.95 |
| Basic Shares Outstanding | 1267000000 | 1259000000 | 1285000000 | 1312000000 | 1319000000 |
| Diluted Shares Outstanding | 1267000000 | 1259000000 | 1285000000 | 1312000000 | 1319000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
CVS Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 8.5B | 8.6B | 8.2B | 12.9B | 9.4B |
| Short-term Investments | 2.1B | 2.4B | 3.3B | 2.8B | 3.1B |
| Accounts Receivable | 16.3B | 14.6B | 15.6B | 11.7B | 10.5B |
| Inventory | 19.2B | 18.1B | 18.0B | 19.1B | 17.8B |
| Other Current Assets | 5.1B | 3.1B | 3.2B | 2.6B | 5.3B |
| Total Current Assets | 74.7B | 68.6B | 67.9B | 65.6B | 60.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 15.0B | 15.9B | 17.3B | 17.6B | 19.1B |
| Goodwill | 196.5B | 209.9B | 211.8B | 181.1B | 187.3B |
| Intangible Assets | 25.5B | 27.3B | 29.2B | 24.8B | 29.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 5.1B | 4.8B | 4.7B | 4.6B | 4.7B |
| Total Non-Current Assets | 178.8B | 184.6B | 181.9B | 162.6B | 173.0B |
| Total Assets | 253.5B | 253.2B | 249.7B | 228.3B | 233.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 17.6B | 15.9B | 14.9B | 14.8B | 12.5B |
| Short-term Debt | 5.8B | 7.5B | 4.7B | 3.5B | 5.9B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.1B | 1.2B | 2.5B | 2.8B | 5.6B |
| Total Current Liabilities | 88.7B | 84.6B | 79.2B | 69.4B | 67.8B |
| Non-Current Liabilities | |||||
| Long-term Debt | 74.1B | 75.4B | 74.7B | 67.3B | 70.1B |
| Deferred Tax Liabilities | 3.8B | 3.8B | 4.3B | 4.0B | 6.3B |
| Other Non-Current Liabilities | 9.5B | 10.3B | 11.7B | 12.6B | 8.3B |
| Total Non-Current Liabilities | 89.5B | 92.9B | 93.9B | 87.1B | 89.8B |
| Total Liabilities | 178.2B | 177.5B | 173.1B | 156.5B | 157.6B |
| Equity | |||||
| Common Stock | 50.4B | 49.7B | 49.0B | 48.2B | 47.4B |
| Retained Earnings | 61.2B | 62.8B | 61.6B | 56.4B | 54.9B |
| Treasury Stock | 36.8B | 36.8B | 33.8B | 31.9B | 28.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 75.4B | 75.7B | 76.6B | 71.8B | 75.4B |
| Key Metrics | |||||
| Total Debt | 80.0B | 82.9B | 79.4B | 70.7B | 76.0B |
| Working Capital | -14.0B | -16.0B | -11.3B | -3.8B | -7.8B |
Balance Sheet Composition
CVS Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.7B | 4.6B | 8.4B | 4.3B | 8.0B |
| Depreciation & Amortization | 4.6B | 4.6B | 4.4B | 4.2B | 4.5B |
| Stock-Based Compensation | 535.0M | 540.0M | 588.0M | 447.0M | 484.0M |
| Working Capital Changes | -1.5B | -2.6B | -379.0M | 5.8B | 3.8B |
| Operating Cash Flow | 5.1B | 6.0B | 12.7B | 13.1B | 15.9B |
| Investing Activities | |||||
| Capital Expenditures | -2.8B | -2.8B | -3.0B | -2.7B | -2.5B |
| Acquisitions | -436.0M | -95.0M | -16.6B | -1.4B | -146.0M |
| Investment Purchases | -15.0B | -15.2B | -9.0B | -7.7B | -10.0B |
| Investment Sales | 12.4B | 10.4B | 7.7B | 6.7B | 7.2B |
| Investing Cash Flow | -5.9B | -7.6B | -20.9B | -5.0B | -5.3B |
| Financing Activities | |||||
| Share Repurchases | 0 | -3.0B | -2.0B | -3.5B | 0 |
| Dividends Paid | -3.4B | -3.4B | -3.1B | -2.9B | -2.6B |
| Debt Issuance | 4.0B | 7.9B | 10.9B | 0 | 987.0M |
| Debt Repayment | -5.7B | -4.8B | -8.2B | -4.2B | -10.3B |
| Financing Cash Flow | -7.5B | -1.5B | -2.6B | -11.1B | -11.9B |
| Free Cash Flow | 7.8B | 6.3B | 10.4B | 13.4B | 15.7B |
| Net Change in Cash | -8.2B | -3.1B | -10.8B | -3.0B | -1.2B |
Cash Flow Trend
CVS Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
55.65
Forward P/E
9.45
Price to Book
1.31
Price to Sales
0.25
PEG Ratio
0.72
Profitability Ratios
Profit Margin
0.44%
Operating Margin
1.57%
Return on Equity
2.29%
Return on Assets
2.47%
Financial Health
Current Ratio
0.84
Debt to Equity
106.06
Beta
0.50
Per Share Data
EPS (TTM)
$1.39
Book Value per Share
$59.18
Revenue per Share
$315.58
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CVS | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| Cigna | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
| Humana | 25.8B | 21.84 | 1.47 | 7.04% | 0.92% | 74.82 |
| Centene | 20.2B | 8.06 | 1.01 | -28.68% | -3.79% | 90.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.






